Trial Profile
A Two-way Cross-over, Placebo-controlled Interaction Trial in Two Parts (in Healthy Subjects), Studying Liraglutide's Potential Influence on the Absorption Pharmacokinetics of Lisinopril, Atorvastatin, Griseofulvin and Digoxin, and Liraglutide's Potential Influence on Intragastric pH
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jan 2017
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Atorvastatin; Digoxin; Griseofulvin; Lisinopril
- Indications Arrhythmias; Cardiovascular disorders; Diabetes mellitus; Heart failure; Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 27 Jan 2012 New trial record